A Study Evaluating ClariVein With a Sclerosing Agent for the Treatment of Venous Insufficiency

Stopped early · Phase 2

Conditions studied: Venous Insufficiency

In brief

VICARES is a prospective randomized, controlled, multi-center, double blind study treating venous insufficiency associated with incompetent saphenous veins with 1% and 3% Sodium Tetradecyl Sulfate (STS) solution utilizing the ClariVein system.

Key facts

Study ID
NCT03311269
Run by
Vascular Insights, LLC
People needed
19
Starts
2017-09-22
Expected to finish
2020-03-27
Last updated by the study team
2022-03-02

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.